Results 211 to 220 of about 73,992 (251)

Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Lancet, The, 2022
Eduardo Marbán, Suzanne Hendrix, Richard S Finkel   +2 more
exaly  

Duchenne's Cardiomyopathy

Acta Cardiologica, 2006
GUO, Hangyuan, SHEN, Jianyao, LEE, Jong-Dae   +2 more
openaire   +1 more source

Therapeutic approaches for Duchenne muscular dystrophy

Nature Reviews Drug Discovery, 2023
Thomas C Roberts, Kay E Davies
exaly  

DUCHENNE DE BOULOGNE

Australian and New Zealand Journal of Surgery, 1979
openaire   +2 more sources

Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study

Lancet, The, 2018
Tina Duong, Eric P Hoffman, Heather Gordish-Dressman   +2 more
exaly  

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

Lancet, The, 2011
Sebahattin Cirak, V Arechavala-Gomeza, Michela Guglieri   +2 more
exaly  

Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial

Lancet, The, 2015
Thomas Voit, Ulrike schara, Maria Grazia D'Angelo   +2 more
exaly  

Duchenne Muscular Dystrophy

Pediatrics In Review, 2006
openaire   +2 more sources

Steroids in Duchenne dystrophy

Neuromuscular Disorders, 2013
Mayana, Zatz, Rita C M, Pavanello
openaire   +4 more sources

Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in the Netherlands: a cohort study

Lancet, The, 1999
Egbert Bakker
exaly